Hong Jin

2PUBLICATIONS
14CO-AUTHORS
Pacific Peoples life courseMolecular targets
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (2)

Sort by Publication Date:
|Jul 04, 2025
Safety and immunogenicity of intranasal parainfluenza virus type 5 (PIV5)-vectored COVID-19 vaccine in adults and teens in an open-label phase 1 trial.

Paul Spearman, Hong Jin, Peng Xiao

|Jul 05, 2021
Recombinant Newcastle Disease Virus Immunotherapy Drives Oncolytic Effects and Durable Systemic Antitumor Immunity.

James Harper, Shannon Burke, Jon Travers

Pageof 1

Frequent Collaborators

1 joint publications

Rebecca Leyland

1 joint publications

Kathy Mulgrew

1 joint publications

Paul Spearman

1 joint publications

Peng Xiao

1 joint publications

Kristeene Knopp

1 joint publications

Marinka Tellier

1 joint publications

Sasha E Larsen

1 joint publications

Jamie Kidd

1 joint publications

Karnail Singh

1 joint publications

Samuel Wu

Frequent Collaborators

1 joint publications

Rebecca Leyland

1 joint publications

Kathy Mulgrew

1 joint publications

Paul Spearman

1 joint publications

Peng Xiao

JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies
Jove
Visualize
Contact Us

Top Related Videos

Preparation, Characteristics, Toxicity, and Efficacy Evaluation of the Nasal Self-Assembled Nanoemulsion Tumor Vaccine <em>In Vitro</em> and <em>In Vivo</em>
07:33

Preparation, Characteristics, Toxicity, and Efficacy Evaluation of the Nasal Self-Assembled Nanoemulsion Tumor Vaccine <em>In Vitro</em> and <em>In Vivo</em>

Published on : Sep 28, 2022

1.9K
Production of High-Titer Recombinant Newcastle Disease Virus from Allantoic Fluid
07:24

Production of High-Titer Recombinant Newcastle Disease Virus from Allantoic Fluid

Published on : May 25, 2022

4.0K
See more related videos

Top Related Videos

Preparation, Characteristics, Toxicity, and Efficacy Evaluation of the Nasal Self-Assembled Nanoemulsion Tumor Vaccine <em>In Vitro</em> and <em>In Vivo</em>
07:33

Preparation, Characteristics, Toxicity, and Efficacy Evaluation of the Nasal Self-Assembled Nanoemulsion Tumor Vaccine <em>In Vitro</em> and <em>In Vivo</em>

Published on : Sep 28, 2022

1.9K
Production of High-Titer Recombinant Newcastle Disease Virus from Allantoic Fluid
07:24

Production of High-Titer Recombinant Newcastle Disease Virus from Allantoic Fluid

Published on : May 25, 2022

4.0K
See more related videos